A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

Recruiting now · Phase 2 · Has a placebo group

Conditions studied: Diffuse Cutaneous Systemic Sclerosis

In brief

The purpose of this study is to evaluate efficacy, safety and tolerability of s.c. ianalumab administered in participants with diffuse cutaneous systemic sclerosis relative to placebo

Key facts

Study ID

NCT06470048

Run by

Novartis Pharmaceuticals

People needed

200

Starts

2024-10-09

Expected to finish

2034-07-31

Last updated by the study team

2026-07-10

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

Where it is running

• UCLA — Los Angeles, California, United States (enrolling)
• Hoag Hospital — Newport Beach, California, United States (enrolling)
• Clinical Res Of W Florida — Clearwater, Florida, United States (enrolling)
• GNP Research — Cooper City, Florida, United States (enrolling)
• IRIS Research and Development — Plantation, Florida, United States (enrolling)
• Sarasota Arthritis Res Ctr — Sarasota, Florida, United States (enrolling)
• University of Chicago Hospitals — Chicago, Illinois, United States (enrolling)
• UMC New Orleans — New Orleans, Louisiana, United States (enrolling)
• Uni Of Michigan Health System — Ann Arbor, Michigan, United States (enrolling)
• Wayne State University — Detroit, Michigan, United States (enrolling)
• Clinical Research Inst of MI — Saint Clair Shores, Michigan, United States (enrolling)
• Hospital for Special Surgery — New York, New York, United States (enrolling)
• West Tennessee Research Institute — Jackson, Tennessee, United States (enrolling)
• Arthritis and Rheumatology Ins — Allen, Texas, United States (enrolling)
• Novel Research LLC — Bellaire, Texas, United States (enrolling)
• Prolato Clinical Research Center — Houston, Texas, United States (enrolling)
• Novartis Investigative Site — CABA, Buenos Aires, Argentina (enrolling)
• Novartis Investigative Site — CABA, Buenos Aires, Argentina (enrolling)
• Novartis Investigative Site — Caba, Argentina (enrolling)
• Novartis Investigative Site — Caba, Argentina (enrolling)
• Novartis Investigative Site — San Miguel de Tucumán, Argentina (enrolling)
• Novartis Investigative Site — Graz, Austria (enrolling)
• Novartis Investigative Site — Leuven, Belgium (enrolling)
• Novartis Investigative Site — Salvador, Estado de Bahia, Brazil (enrolling)
• Arizona Arthritis and Rheumatology Research PLLC — Mesa, Arizona, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.